4.6 Article

Practical fecal calprotectin cut-off value for Japanese patients with ulcerative colitis

Related references

Note: Only part of the references are listed.
Article Gastroenterology & Hepatology

Fecal Calprotectin in Assessing Endoscopic and Histological Remission in Patients with Ulcerative Colitis

Wing Yan Mak et al.

DIGESTIVE DISEASES AND SCIENCES (2018)

Article Gastroenterology & Hepatology

Fecal Calprotectin Levels Predict Histological Healing in Ulcerative Colitis

Anish Patel et al.

INFLAMMATORY BOWEL DISEASES (2017)

Article Gastroenterology & Hepatology

Comparison of Fecal Calprotectin Methods for Predicting Relapse of Pediatric Inflammatory Bowel Disease

Saranya Kittanakom et al.

CANADIAN JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY (2017)

Article Gastroenterology & Hepatology

Evaluation of the Risk of Relapse in Ulcerative Colitis According to the Degree of Mucosal Healing (Mayo 0 vs 1): A Longitudinal Cohort Study

Manuel Barreiro-de Acosta et al.

JOURNAL OF CROHNS & COLITIS (2016)

Article Gastroenterology & Hepatology

Fecal calprotectin is a clinically relevant biomarker of mucosal healing in patients with quiescent ulcerative colitis

Sayaka Yamaguchi et al.

JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY (2016)

Article Gastroenterology & Hepatology

Fecal Calprotectin Predicts Relapse and Histological Mucosal Healing in Ulcerative Colitis

Klaus Theede et al.

INFLAMMATORY BOWEL DISEASES (2016)

Article Gastroenterology & Hepatology

Selecting Therapeutic Targets in Inflammatory Bowel Disease (STRIDE): Determining Therapeutic Goals for Treat-to-Target

L. Peyrin-Biroulet et al.

AMERICAN JOURNAL OF GASTROENTEROLOGY (2015)

Article Medicine, General & Internal

Fecal calprotectin and ulcerative colitis endoscopic activity index as indicators of mucosal healing in ulcerative colitis

Tarang Taghvaei et al.

INTERNAL AND EMERGENCY MEDICINE (2015)

Article Gastroenterology & Hepatology

Fecal Level of Calprotectin Identifies Histologic Inflammation in Patients With Ulcerative Colitis in Clinical and Endoscopic Remission

Jordi Guardiola et al.

CLINICAL GASTROENTEROLOGY AND HEPATOLOGY (2014)

Article Gastroenterology & Hepatology

Accuracy of Advanced Endoscopy and Fecal Calprotectin for Prediction of Relapse in Ulcerative Colitis: A Prospective Study

Aranzazu Jauregui-Amezaga et al.

INFLAMMATORY BOWEL DISEASES (2014)

Article Gastroenterology & Hepatology

Comparison of six different calprotectin assays for the assessment of inflammatory bowel disease

Delphine Labaere et al.

UNITED EUROPEAN GASTROENTEROLOGY JOURNAL (2014)

Article Gastroenterology & Hepatology

Atypical distribution of inflammation in newly diagnosed ulcerative colitis is not rare

Sang Hyoung Park et al.

CANADIAN JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY (2014)

Article Gastroenterology & Hepatology

Histologic Markers of Inflammation in Patients With Ulcerative Colitis in Clinical Remission

Laura Rosenberg et al.

CLINICAL GASTROENTEROLOGY AND HEPATOLOGY (2013)

Review Gastroenterology & Hepatology

Mucosal healing in inflammatory bowel disease: Treatment efficacy and predictive factors

Claudio Papi et al.

DIGESTIVE AND LIVER DISEASE (2013)

Article Gastroenterology & Hepatology

Prognostic Value of Serologic and Histologic Markers on Clinical Relapse in Ulcerative Colitis Patients With Mucosal Healing

Talat Bessissow et al.

AMERICAN JOURNAL OF GASTROENTEROLOGY (2012)

Review Gastroenterology & Hepatology

Mucosal healing in inflammatory bowel diseases: a systematic review

Markus F. Neurath et al.

Article Gastroenterology & Hepatology

Majority of patients with inflammatory bowel disease in clinical remission have mucosal inflammation

Judith E. Baars et al.

INFLAMMATORY BOWEL DISEASES (2012)

Article Gastroenterology & Hepatology

Mucosal Healing Predicts Late Outcomes After the First Course of Corticosteroids for Newly Diagnosed Ulcerative Colitis

Sandro Ardizzone et al.

CLINICAL GASTROENTEROLOGY AND HEPATOLOGY (2011)

Article Gastroenterology & Hepatology

Early Mucosal Healing With Infliximab Is Associated With Improved Long-term Clinical Outcomes in Ulcerative Colitis

Jean Frederic Colombel et al.

GASTROENTEROLOGY (2011)

Article Gastroenterology & Hepatology

Does fecal calprotectin predict relapse in patients with Crohn's disease and ulcerative colitis?

Valle Garcia-Sanchez et al.

JOURNAL OF CROHNS & COLITIS (2010)

Article Gastroenterology & Hepatology

Fecal Calprotectin and Lactoferrin for the Prediction of Inflammatory Bowel Disease Relapse

Javier P. Gisbert et al.

INFLAMMATORY BOWEL DISEASES (2009)

Article Gastroenterology & Hepatology

Mucosal healing in inflammatory bowel disease: Results from a Norwegian population-based cohort

Kathrine Frey Froslie et al.

GASTROENTEROLOGY (2007)

Article Medicine, General & Internal

Infliximab for induction and maintenance therapy for ulcerative colitis

P Rutgeerts et al.

NEW ENGLAND JOURNAL OF MEDICINE (2005)

Article Gastroenterology & Hepatology

Severity of inflammation is a risk factor for colorectal neoplasia in ulcerative colitis

M Rutter et al.

GASTROENTEROLOGY (2004)

Article Gastroenterology & Hepatology

Clinical, biological, and histologic parameters as predictors of relapse in ulcerative colitis

A Bitton et al.

GASTROENTEROLOGY (2001)